Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

BACKGROUND: Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal cancer. METHODS: All serious adverse events that...

書誌詳細
主要な著者:	Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Stanley, A, Stokes, J, Julier, P, Iveson, C, Duvvuri, R, McConkey, C
フォーマット:	Journal article
言語:	English
出版事項:	2007

類似資料

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
著者:: Midgley, R, 等
出版事項: (2010)

VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
著者:: Kerr, D, 等
出版事項: (2008)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
著者:: Midgley, R, 等
出版事項: (2008)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
著者:: Gray, R, 等
出版事項: (2007)

Adjuvant therapy of colorectal cancer.
著者:: Midgley, R, 等
出版事項: (2000)

ABC of colorectal cancer: adjuvant therapy.
著者:: Midgley, R, 等
出版事項: (2000)

QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.
著者:: Gray, R, 等
出版事項: (2004)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
著者:: Kerr, D, 等
出版事項: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
著者:: Kerr, D, 等
出版事項: (2000)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
著者:: Midgley, R, 等
出版事項: (2005)

QUASAR Collaborative Group: a randomised study of adjuvant chemotherapy (CT) vs observation in predominantly stage II colorectal cancer
著者:: Kerr, D, 等
出版事項: (2004)

Rofecoxib Induced Purpura
著者:: Dogra Sunil, 等
出版事項: (2004-01-01)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
著者:: Midgley, R, 等
出版事項: (2005)

The NSAID roller coaster: more about rofecoxib.
著者:: Aronson, J
出版事項: (2006)

CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL
著者:: Midgley, R, 等
出版事項: (2012)

Rofecoxib, Diclofenac e Indometacina aumentam o risco de doença cardiovascular
著者:: Filipa Almada Lobo
出版事項: (2006-11-01)

Simultaneous Determination of Rofecoxib and Tizanidine by HPTLC
著者:: Uttam D. Pawar, 等
出版事項: (2009-01-01)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
著者:: McQuay Henry J, 等
出版事項: (2004-07-01)

Rofecoxib-Induced Hepatotoxicity: A Forgotten Complication of the Coxibs
著者:: Brian Yan, 等
出版事項: (2006-01-01)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
著者:: Edwards, J, 等
出版事項: (2004)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
著者:: McQuay Henry J, 等
出版事項: (2004-02-01)

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
著者:: Sacchi Ada, 等
出版事項: (2010-02-01)

Adjuvant chemotherapy for colorectal cancer.
著者:: Kerr, D, 等
出版事項: (1996)

Rofecoxib improves quality of life in patients with hip or knee osteoarthritis
著者:: R Theiler, 等
出版事項: (2002-10-01)

Single dose oral rofecoxib for acute postoperative pain in adults.
著者:: Bulley, S, 等
出版事項: (2009)

Single dose oral rofecoxib for acute postoperative pain in adults.
著者:: Bulley, S, 等
出版事項: (2009)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
著者:: Barden, J, 等
出版事項: (2002)

The effect of rofecoxib and diclofenac on blood picture in male patients
著者:: Mohammed Z.K. Al-Hayali
出版事項: (2008-12-01)

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
著者:: Boyd Kathleen A, 等
出版事項: (2011-12-01)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
著者:: McQuay Henry J, 等
出版事項: (2002-06-01)

Immunotherapy for colorectal cancer.
著者:: Midgley, R, 等
出版事項: (2003)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
著者:: Rozires P. Leão, 等
出版事項: (2020-08-01)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
出版事項: (2004)

Colorectal cancer.
著者:: Nicum, S, 等
出版事項: (2003)

Colorectal cancer
著者:: Nicum, S, 等
出版事項: (2003)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
著者:: Midgley, R, 等
出版事項: (2013)

Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice
著者:: Fran Norflus, 等
出版事項: (2004-11-01)

Chemotherapy for colorectal cancer.
著者:: Nicum, S, 等
出版事項: (2000)

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
著者:: Gábor B. Brenner, 等
出版事項: (2020-02-01)

SKIN PERMEATION ENHANCEMENT EFFECTS OF ASCORBIC ACID AND TRIETHYL CITRATE ON ROFECOXIB
著者:: MALAY K. DAS, 等
出版事項: (2008-01-01)